HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Yoshidome Selected Research

Disease Progression

8/2008Hyperbaric oxygen therapy as a prophylactic and treatment against ileus and recurrent intestinal obstruction soon after surgery to relieve adhesive intestinal obstruction.
8/2007Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Yoshidome Research Topics

Disease

41Neoplasms (Cancer)
09/2021 - 05/2003
15Neoplasm Metastasis (Metastasis)
09/2021 - 05/2003
10Pancreatic Neoplasms (Pancreatic Cancer)
05/2017 - 10/2003
8Hepatocellular Carcinoma (Hepatoma)
01/2014 - 05/2003
7Carcinoma (Carcinomatosis)
03/2021 - 10/2004
7Klatskin Tumor
07/2010 - 04/2005
6Obstructive Jaundice (Cholestatic Jaundice)
07/2012 - 04/2005
6Infections
05/2009 - 06/2004
5Cholangiocarcinoma
04/2011 - 01/2004
5Ischemia
03/2011 - 03/2004
4Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2015 - 10/2008
4Thrombosis (Thrombus)
11/2015 - 09/2004
3Liver Diseases (Liver Disease)
06/2020 - 06/2009
3Reperfusion Injury
03/2011 - 03/2004
3Neuroendocrine Carcinoma
04/2010 - 01/2008
3Colorectal Neoplasms (Colorectal Cancer)
04/2009 - 07/2005
3Intestinal Obstruction (Obstruction, Intestinal)
08/2008 - 10/2007
2Sepsis (Septicemia)
07/2013 - 09/2010
2Necrosis
09/2010 - 10/2004
2Endotoxemia
09/2010 - 10/2004
2Cholestasis
07/2010 - 04/2006
2Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2010 - 11/2008
2Lung Injury
01/2010 - 07/2005
2Edema (Dropsy)
01/2010 - 03/2004
2Adenocarcinoma
12/2009 - 06/2009
2Pathologic Constriction (Stenosis)
01/2009 - 07/2008
2Disease Progression
08/2008 - 08/2007
2Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
08/2008 - 10/2007
2Margins of Excision
07/2008 - 01/2007
2Sigmoid Neoplasms
11/2007 - 11/2007
2Uterine Neoplasms (Uterine Cancer)
11/2006 - 10/2004
2Liver Failure
04/2005 - 10/2004
1Disseminated Intravascular Coagulation
03/2021
1Stomach Neoplasms (Stomach Cancer)
03/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
05/2017
1Portal Hypertension
01/2014
1Carcinogenesis
02/2012
1Thrombocytopenia (Thrombopenia)
11/2011
1Fatty Liver
03/2011
1Fistula
11/2010
1Cholangitis
05/2010
1Adenoma (Adenomas)
05/2010

Drug/Important Bio-Agent (IBA)

7GemcitabineFDA Link
12/2015 - 10/2003
7Proteins (Proteins, Gene)FDA Link
01/2014 - 03/2006
5Messenger RNA (mRNA)IBA
02/2012 - 05/2003
4CytokinesIBA
09/2010 - 03/2004
4Interleukin-6 (Interleukin 6)IBA
03/2009 - 06/2004
3Indicators and Reagents (Reagents)IBA
06/2020 - 11/2008
3AntigensIBA
01/2012 - 05/2005
3MucinsIBA
04/2011 - 05/2010
3NF-kappa B (NF-kB)IBA
09/2010 - 03/2004
3Biological ProductsIBA
06/2009 - 07/2008
3Oxygen (Dioxygen)IBA
08/2008 - 10/2007
2TOR Serine-Threonine KinasesIBA
09/2021 - 04/2010
2Cisplatin (Platino)FDA LinkGeneric
12/2015 - 05/2005
2Annexin A2 (Annexin II)IBA
12/2012 - 11/2008
2Small Interfering RNA (siRNA)IBA
02/2012 - 11/2008
2CarbohydratesIBA
01/2012 - 05/2005
2Alanine Transaminase (SGPT)IBA
03/2011 - 06/2004
2BismuthIBA
07/2010 - 02/2010
2Interleukin-18 (Interleukin 18)IBA
01/2010 - 03/2004
2Transcription Factors (Transcription Factor)IBA
12/2009 - 11/2008
2DNA (Deoxyribonucleic Acid)IBA
06/2009 - 07/2008
2Angiopoietin-2IBA
04/2009 - 07/2008
2Interleukin-10 (Interleukin 10)IBA
03/2009 - 06/2006
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2008 - 07/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2008 - 07/2005
2Biotin (Vitamin H)FDA Link
07/2008 - 03/2004
2Interleukin-8 (Interleukin 8)IBA
06/2006 - 03/2006
2Peroxidase (Myeloperoxidase)IBA
10/2004 - 03/2004
1Biomarkers (Surrogate Marker)IBA
09/2021
1Dacarbazine (DIC)FDA LinkGeneric
03/2021
1A-factor (Streptomyces)IBA
12/2012
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
02/2012
1Recombinant ProteinsIBA
02/2012
1Cetuximab (Erbitux)FDA Link
11/2011
1Peroxynitrous Acid (Peroxynitrite)IBA
03/2011
1pimagedine (aminoguanidine)IBA
03/2011
1Phosphates (Orthophosphate)IBA
03/2011
1Hepatocyte Nuclear FactorsIBA
09/2010
1Endothelin-1 (Endothelin 1)IBA
07/2010
1MTOR InhibitorsIBA
04/2010
1EverolimusFDA Link
04/2010

Therapy/Procedure

24Hepatectomy
11/2015 - 10/2003
13Drug Therapy (Chemotherapy)
03/2021 - 11/2004
10Therapeutics
12/2015 - 10/2003
8Pancreaticoduodenectomy
05/2017 - 03/2006
4Splenectomy
01/2014 - 11/2002
4Ligation
07/2013 - 11/2008
4Operative Surgical Procedures
05/2012 - 04/2005
3Pancreatectomy
05/2017 - 10/2004
3Liver Transplantation
01/2014 - 07/2005
3Adjuvant Chemotherapy
12/2012 - 11/2008
3Hyperbaric Oxygenation
08/2008 - 10/2007
2Colectomy
11/2015 - 11/2009
2Transplantation
01/2014 - 03/2011
2Stents
01/2009 - 11/2006
1Laparotomy
05/2017
1Punctures
07/2013
1Neoadjuvant Therapy
10/2012